IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $440 | -35.3% | 96,618 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $680 | +15.3% | 96,618 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $590 | -9.0% | 96,618 | -4.7% | 0.00% | -20.0% |
| Q4 2022 | $648 | -99.9% | 101,374 | -5.5% | 0.01% | -37.5% |
| Q3 2022 | $1,027,000 | +97.1% | 107,249 | +127.2% | 0.01% | +100.0% |
| Q2 2022 | $521,000 | -33.7% | 47,210 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $786,000 | -14.3% | 47,210 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $917,000 | -21.2% | 47,210 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $1,164,000 | +97.3% | 47,210 | +108.3% | 0.01% | +50.0% |
| Q2 2021 | $590,000 | -17.8% | 22,666 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $718,000 | – | 22,666 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |